№ files_lp_4_process_1_43249
File format: docx Character count: 1166 File size: 54 KB
A survey aimed at assessing the time between the onset of symptoms and the diagnosis of Axial Spondyloarthropathy, conducted by the National Axial Spondyloarthritis Society.
Year: 2022
Region / City: Wales
Topic: Axial Spondyloarthropathy
Document Type: Survey Invitation
Organization / Institution: National Axial Spondyloarthritis Society (NASS)
Author: National Axial Spondyloarthritis Society (NASS)
Target Audience: Patients recently diagnosed with Axial Spondyloarthropathy (Axial Spondyloarthritis, Ankylosing Spondylitis, or Axial SpA)
Duration: N/A
Approval Date: N/A
Revision Date: N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Management of Newly Diagnosed Type 1 Diabetes Mellitus in Children at Canberra Health Services
Year: 2024
Region / City: Canberra, Australia
Topic: Paediatric Diabetes Care
Document Type: Clinical Guideline
Organization: Canberra Health Services, Paediatric Endocrinology & Diabetes Service (PEDS)
Target Audience: Paediatric endocrinologists, medical officers, ward nursing staff, diabetes educators
Age Group: Children and adolescents 0–16 years
Scope: Inpatient management of newly diagnosed Type 1 Diabetes Mellitus
Exclusions: Diabetic Ketoacidosis management, Type 2 Diabetes, Cystic Fibrosis Related Diabetes, pre-existing T1DM, outpatient management
Venclexta® (Venetoclax) Tablet 100 mg, 50 mg, Request for Authority Listing for Treatment of Newly Diagnosed Acute Myeloid Leukaemia Ineligible for Intensive Chemotherapy
Year: 2021
Region / city: Australia
Topic: Pharmaceutical Drug Submission
Document type: Resubmission Request
Organization / institution: PBAC
Author: AbbVie Pty Ltd.
Target audience: Healthcare professionals, PBAC
Validity period: Not specified
Approval date: 2021
Date of amendments: Not specified
Call for Quotations for Field Investigator-cum-Laboratory Technician for Research Project on Type of Anemia in Patients with Newly Diagnosed Diabetes Mellitus
Year: 2022
Region / City: Kangra, Himachal Pradesh
Subject: Health
Document Type: Call for Quotations
Organization / Institution: Dr. Rajendra Prasad Government Medical College
Author: Dr. Rashmi Kaul, Prof & Head of Dept. of Pathology
Target Audience: Contractors, Individuals/Agencies for Research Project
Duration: 12 months
Approval Date: 19/3/2022
Amendment Date: 19/4/2022
Contextual Description: A call for quotations for outsourcing a field investigator-cum-laboratory technician for a research project on anemia in diabetic patients at Dr. Rajendra Prasad Government Medical College.
National Institute for Health and Care Excellence Single Technology Appraisal Appeal Hearing Advice on abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer [ID945] Decision of the Panel
Year: 2020
Region / City: United Kingdom
Topic: Prostate Cancer, Oncology, Drug Evaluation
Document Type: Appeal Hearing Transcript
Organization: National Institute for Health and Care Excellence (NICE)
Author: Various panel members, including Heather Blake, Professor Nicholas James, and others
Target Audience: Healthcare professionals, decision-makers, cancer advocacy groups
Effective Period: September 2020
Approval Date: 3 September 2020
Date of Changes: None
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Year: 2018
Region / city: Northern Ireland
Topic: Cancer survival trends, international comparison
Document type: Research paper
Organization / institution: NICR
Author: Claudia Allemani, Tomohiro Matsuda, Veronica Di Carlo, Michel P Coleman, et al.
Target audience: Health professionals, researchers, policymakers
Effective period: 2000–2014
Approval date: Not specified
Date of changes: Not specified
Journal: Lancet
DOI: doi.org/10.1016/S0140-6736(17)33326-3
Funders: International contributors including Cancer Focus and Public Health Agency via NICR
Conclusion: International differences in cancer survival exist
What this means for the service: Northern Ireland compares well for cancer survival internationally but not when compared to similar countries in Europe.
Anatomy Worksheet 3: The Axial Skeletal System (Skull)
Note: Year
Subject: Anatomy
Document Type: Educational Worksheet
Target Audience: Students of Anatomy
Keywords: bones, skull, axial skeleton, anatomical features, exercises
Aerovent Guide Specification Section 23 34 23.03 – Axial Roof Ventilators, Model BSHD, Direct-Driven (2017)
Year: 2017
Company: Aerovent
Headquarters Location: Minneapolis, Minnesota, United States
Document Type: Guide Specification
Section Number: 23 34 23.03
Product Model: BSHD Series
Product Type: Axial Roof Ventilators, Direct-Driven
Certifications: UL/cUL 705 Listed; ISO 9001
Referenced Standards: AMCA 204; AMCA 210; AMCA 300; AMCA 211; AMCA 311; NEMA MG 1; NFPA 70
Impeller Diameter Range: 14 to 48 inches (356 mm to 1,219 mm)
Maximum Airflow: Up to 32,200 CFM (54,700 m3/hour)
Maximum Static Pressure: Up to 1 inch wg (248 Pa)
Warranty Period: 12 months from startup or 18 months from shipment
Applications: Commercial and light industrial ventilation
Manufacturing Space: Over 1,000,000 sq. ft. in the United States
Contact Information: (763) 551-7500; [email protected]
Note: ; www.aerovent.com
Executive summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs
Year: 2025
Region / city: UK
Topic: Rheumatology, Axial Spondyloarthritis
Document type: Guideline
Organization / institution: British Society for Rheumatology
Author: Sizheng Steven Zhao, Stephanie R Harrison, Ben Thompson, Max Yates, Joe Eddison, Antoni Chan, Nick Clarke, Nadia Corp, Charlotte Davis, Lambert Felix, Kalveer Flora, William J Gregory, Gareth T Jones, Christopher A Lamb, Helena Marzo-Ortega, Daniel J Murphy, Harry Petrushkin, Virinderjit Sandhu, Raj Sengupta, Stefan Siebert, Danielle A Van Der Windt, Dale Webb, Zenas Z N Yiu, Karl Gaffney
Target audience: Health professionals, rheumatologists
Period of validity: Ongoing
Approval date: 2025
Date of changes: Not specified
Context: This is a clinical guideline for treating axial spondyloarthritis with biologic and targeted synthetic DMARDs.
Supplementary Figure 1: CT Scan of a Bionic Artificial Atlanto-Odontoid Joint Implanted in a Specimen (Plain, Axial, Coronal, and 3D Reconstruction)
Section: Supplementary Figure Legend
Figure number: Supplementary Figure 1
Imaging modality: CT scan
Image views: Plain CT scan (A, B, C); Axial CT scan (D); Coronal CT scan (E); 3D reconstruction of CT images (F)
Subject: Bionic artificial atlanto-odontoid joint
Anatomical region: Atlanto-odontoid joint of the cervical spine
Specimen type: Implanted specimen
Field of study: Biomedical engineering / Orthopedic research
Content focus: Visualization of an implanted artificial joint using multiple CT imaging perspectives
Topics: Spondyloarthropathy Diagnosed Axial